ADCTA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADCTA, covering 2020-03-17 to 2020-03-17. Get the full timeline:
Most recent: Clinical Trial Update: ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM) [Phase 3]